Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2022-11-15 Investor Presentation
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
本公司受邀參加大和國泰證券舉辦之非籌資巡迴說明會(Non-deal roadshow)
Investor Presentation Classification · 95% confidence The document is a brief announcement about the company participating in a non-deal roadshow (a type of investor presentation) organized by securities firms. It includes details such as dates, times, location, and the purpose of the event (explaining financial and operational status to investors). The document does not contain actual financial statements or detailed analysis, but rather information about an upcoming or recent investor presentation event. It is not a full report, earnings release, or regulatory filing. Therefore, the most appropriate classification is Investor Presentation (IP). The document length is short and it is not merely announcing the publication of a report, but describing the event itself.
2022-11-15 Chinese
111年第3季海外子公司投資
Financial Supplement Data Classification · 85% confidence The document contains detailed financial data about investments in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses. It references accounting standards and provides notes explaining the figures. The content is financial and analytical but does not appear to be a full annual or quarterly report, nor is it a brief announcement or certification. The document length is 2260 characters, which is relatively short and more consistent with a financial supplement or detailed financial data table rather than a full report. There is no indication that this is an announcement of a report or a certification. Given the detailed tabular financial data, this fits best as Financial Supplement Data (XLSX), even though the format here is text, the nature of the content aligns with supplementary financial data rather than a full report or announcement.
2022-11-14 Chinese
111年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment information related to the company's investments in mainland China, including capital amounts, investment methods, cumulative investment amounts, and recognized investment gains or losses. It includes notes explaining the investment methods and accounting bases for investment gains/losses. The document is relatively short (1443 characters) and does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure related to investment activities rather than a full financial report or earnings release. There is no indication that this is an announcement of a report publication or a certification. Given the nature of the content and the lack of fit with other specific categories, this document best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2022-11-14 Chinese
111年第3季財務報告書 — 202204_1795_AIC.pdf
Audit Report / Information Classification · 95% confidence The document is titled 'Parent-Company-Only Financial Statements With Independent Auditors’ Report For the Years Ended December 31, 2022 and 2021' and includes detailed financial statements such as balance sheets, statements of comprehensive income, changes in equity, cash flows, and notes to the financial statements. It also contains an Independent Auditors’ Report with an opinion on the financial statements, audit basis, key audit matters, and responsibilities of management and auditors. The content is comprehensive and includes substantive financial data and analysis for a full fiscal year, indicating it is a formal financial report rather than a brief announcement or certification. The presence of an auditor's report and detailed financial statements aligns with the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and applied accounting principles, excluding full annual reports. The document is not a full Annual Report (10-K) as it focuses on parent-company-only financial statements and the auditor's report without broader company activity or management discussion. Therefore, the appropriate classification is AR with high confidence. FY 2022
2022-11-14 Chinese
111年第3季財務報告書 — 202204_1795_AIA.pdf
Annual Report Classification · 100% confidence The document is titled 'Consolidated Financial Statements With Independent Auditors’ Report For the Years Ended December 31, 2022 and 2021' and includes detailed financial statements such as balance sheets, statements of comprehensive income, changes in equity, cash flows, and notes. It also contains an independent auditor's report with an opinion on the consolidated financial statements, audit basis, key audit matters, and responsibilities of management and auditors. The content is comprehensive and covers a full fiscal year, indicating it is a full annual financial report. There is no indication that this is merely an announcement or a certification letter. Therefore, this document fits the definition of an Annual Report (10-K) filing, which is the official yearly report covering company activity and full financial performance. FY 2022
2022-11-14 Chinese
111年第3季財務報告書 — 202204_1795_AI3.pdf
Audit Report / Information Classification · 95% confidence The document is titled as an individual financial report and auditor's audit report for the fiscal years 111 and 110 (Taiwanese calendar years). It contains detailed financial statements such as balance sheets, income statements, cash flow statements, notes on accounting policies, and auditor's opinion. The presence of an auditor's report with audit opinion and detailed financial data indicates this is a standalone audit report rather than a full annual report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2022
2022-11-14 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.